Quarterly report pursuant to Section 13 or 15(d)

Document And Entity Information

v3.23.3
Document And Entity Information - shares
 9 Months Ended
Sep. 30, 2023
Nov. 09, 2023
Document Information [Line Items]    
Entity Central Index Key 0001583648  
Entity Registrant Name PIERIS PHARMACEUTICALS, INC.  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2023  
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Sep. 30, 2023  
Document Transition Report false  
Entity File Number 001-37471  
Entity Incorporation, State or Country Code NV  
Entity Tax Identification Number 30-0784346  
Entity Address, Address Line One 225 Franklin Street, 26th Floor  
Entity Address, City or Town Boston  
Entity Address, State or Province MA  
Entity Address, Postal Zip Code 02110  
City Area Code 857  
Local Phone Number 246-8998  
Title of 12(b) Security Common Stock, $0.001 par value per share  
Trading Symbol PIRS  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   98,851,927